Most people who ask us about drug-free depression care are not anti-medication. They have simply tried it. They took what they were prescribed, waited the weeks, adjusted the dose, and ended up in roughly the same place. Now they want to know what else exists, and whether the insurance card from work will help them get it.
This FAQ is written for people in St. Charles and the surrounding county who have commercial coverage, meaning a plan from an employer or bought on the marketplace. It draws on the answers of 443 adults from ten Midwest states to a survey our publisher commissioned, all of them final and validated.
Is wanting a drug-free option unusual?
Not at all. When we asked about it, a clear majority, 64 percent, said it matters to them that a treatment not depend on medication. You are in the larger group, not the smaller one.
Then why haven't I heard of the options?
Because almost nobody talks about them. In the same survey, one respondent in four, 25 percent, were able to say what TMS is. The other three in four either had never encountered it or could not say what it does. So if your first reaction to the letters "TMS" is a blank stare, you are in good company.
What is TMS, in plain terms?
Transcranial magnetic stimulation is an outpatient treatment in which you sit awake in a chair while a technician holds a magnetic coil to your head. The coil sends pulses that stimulate a region of the brain linked to mood regulation. The FDA cleared TMS for grown patients with major depression that antidepressants have left unresolved. The treatment itself uses neither anesthesia nor medication.
What are the other drug-free routes?
Structured psychotherapy is the most widely available. Electroconvulsive therapy, or ECT, is another established option for severe or stubborn depression, though it does involve anesthesia. Which fits you is a clinical question, not one an article can settle.
Is esketamine one of the drug-free options?
No. Esketamine, sold as Spravato, is a prescription medication. Its FDA approval is for treatment-resistant depression, and every dose must happen in a certified setting, followed by monitoring. It may be worth discussing with your doctor, but if your goal is to avoid medication, it does not qualify. Brain Recovery Centers describes how Spravato care is delivered for comparison.
Will my employer plan cover TMS?
Often, yes, but with conditions. Most commercial plans treat TMS as a medical benefit that requires prior authorization. Common requirements include a confirmed diagnosis of major depression, several antidepressant trials at adequate doses that did not help enough, and sometimes a trial of psychotherapy. The exact number of medication trials varies by plan.
To find your plan's rules, ask member services for the medical policy on transcranial magnetic stimulation. That document is more specific than the summary of benefits you got at open enrollment.
How long does approval take?
Anywhere from a few days to a few weeks, depending on how complete the paperwork is. The most common delay is missing records. If you have seen more than one prescriber over the years, gather the names of the medications you tried, the doses, and roughly how long you took each. Give that list to whoever is filing the request.
What will I actually pay?
That depends on three things: your deductible, your coinsurance or copay, and how many sessions your course includes. A standard TMS course usually means weekday visits for four to six weeks, so even a modest per-session charge multiplies. Many employer plans reset their deductible on January 1, which means timing a course can change your share. Ask the provider for a written estimate after they verify your benefits.
Cost clearly weighs on people. For 65 percent of our respondents, coverage would settle the question of a new depression treatment or weigh heavily on it. Commercial plan holders, 173 in the survey, reached 67 percent on that question. Asking about money is not a distraction from getting well. For many people, it is the gate.
Can I keep working during a course?
Most people do. You can typically drive yourself to and from TMS sessions. The challenge is the schedule, not recovery time. In St. Charles County, where plenty of people commute across the Missouri River on I-70 or Highway 370 every day, a provider on your usual route matters. Among the people we surveyed, 43 percent counted a nearby provider among their top two priorities, behind only insurance coverage.
What if my claim is denied?
A denial is not always the end. You can file an internal appeal with your insurer, and in many cases an external review by an independent reviewer afterward. Ask for the denial reason in writing. Often it points to a specific missing item, such as an undocumented medication trial, that your doctor can supply.
Where do I begin?
Start with your own physician. Close to three quarters of our respondents, 74 percent, singled out their own doctor's recommendation as their likeliest reason to act, far ahead of every other option. Your primary care doctor or psychiatrist can confirm whether TMS or another drug-free route is reasonable for you, document what you have already tried, and send the referral your plan will likely require.
A short list to bring:
- "I would like to understand my drug-free options. Is TMS reasonable for me?"
- "Do my records show the medication trials my plan will ask for?"
- "Can you refer me to an in-network provider near where I live or work?"
This FAQ is not medical advice, and no single treatment helps everybody. The right choice depends on your history, which a clinician can weigh and an article cannot.
If suicidal thoughts are with you, or you do not feel safe right now, set this FAQ aside and reach out. Dial or text 988; from there, a Suicide and Crisis Lifeline counselor takes over, free and private, whatever the hour.
Methodology
Pollfish put this survey before its consumer panel until June 23, 2026; 443 people finished it, all between 18 and 64 and living in Iowa, Oklahoma, Minnesota, Illinois, Kansas, Ohio, Missouri, Indiana, Nebraska, or Wisconsin. Aside from the commercial plan group, figures cover the full sample, and each is final after validation. Funding and the commission for this study both came from the article's publisher.